{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "regularMarketChange": 0.001000002, "regularMarketTime": 1683871252, "regularMarketDayHigh": 0.134, "regularMarketDayRange": "0.134 - 0.134", "regularMarketDayLow": 0.134, "regularMarketVolume": 70, "regularMarketPreviousClose": 0.133, "bid": 0.11, "ask": 0.234, "bidSize": 5000, "askSize": 4061, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 0.134, "averageDailyVolume3Month": 20, "averageDailyVolume10Day": 7, "fiftyTwoWeekLowChange": 0.014000006, "fiftyTwoWeekLowChangePercent": 0.11666672, "fiftyTwoWeekRange": "0.12 - 0.39", "fiftyTwoWeekHighChange": -0.25599998, "fiftyTwoWeekHighChangePercent": -0.6564102, "fiftyTwoWeekLow": 0.12, "fiftyTwoWeekHigh": 0.39, "exchange": "FRA", "shortName": "ENZON PHARMACEUT.  DL-,01", "longName": "Enzon Pharmaceuticals, Inc.", "messageBoardId": "finmb_269599", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": 0.75188124, "regularMarketPrice": 0.134, "earningsTimestamp": 1676581200, "earningsTimestampStart": 1676581200, "earningsTimestampEnd": 1676581200, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.02, "sharesOutstanding": 74214600, "bookValue": 0.046, "fiftyDayAverage": 0.16622, "fiftyDayAverageChange": -0.03221999, "fiftyDayAverageChangePercent": -0.19383945, "twoHundredDayAverage": 0.21404, "twoHundredDayAverageChange": -0.08003999, "twoHundredDayAverageChangePercent": -0.37394878, "marketCap": 13832016, "priceToBook": 2.9130435, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 952066800000, "priceHint": 4, "symbol": "EZ1.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "20 Commerce Drive", "address2": "Suite 135", "city": "Cranford", "state": "NJ", "zip": "07016", "country": "United States", "phone": "732 980 4500", "website": "https://www.enzon.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Richard L. Feinstein", "age": 79, "title": "CEO, CFO & Company Sec.", "yearBorn": 1943, "fiscalYear": 2022, "totalPay": {"raw": 209452, "fmt": "209.45k", "longFmt": "209,452"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}